Company and Stock Identity
How Candid Health Connects to the Public Market
- Company structure
- Private company
- Market access
- No current public listing was verified.
- Research focus
- The group's test applies here: ask whether the automation is measured against denials and rework, not just task volume. Candid Health's own growth figures, 190 percent annual contracted run-rate revenue growth and 180 percent net dollar retention in 2025, describe its sales, not your collections. Ask for denial rate and days in accounts receivable from a practice that looks like yours.
Candid Health announced a 120 million dollar Series D on 22 July 2026, led by Sixth Street Growth with Oak HC/FT, 8VC and Y Combinator taking part, and said the round valued it at three times its February 2025 Series C. No change of control was announced. Checked on 2026-10-10.
Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.
First-Hand Company News
Latest Developments
Candid Health will sell its claims automation through Flatiron Health's oncology records system
Candid Health said on 27 August 2026 that it is partnering with Flatiron Health to bring revenue cycle automation to oncology practices in Flatiron's network, with Flatiron integrating the platform into its OncoEMR records system. Candid Health says OncoEMR is used by more than 5,100 providers and more than 220 community oncology practices across the United States, and that it already does this work for some of the largest oncology organisations in the country.
Why it matters: Selling through the records system a practice already uses removes the hardest part of revenue cycle software, which is the integration. For a community oncology practice this is the difference between a project and a setting. The announcement names no practice that has switched, so the useful question is how many of those 220 actually turn it on and what their denial rate does afterwards. Oncology billing also leans on drug costs and prior authorisation, so general claim automation results do not transfer to it unchanged.
Candid Health raises 120 million dollars and says its value tripled in 17 months
Candid Health said on 22 July 2026 that it raised 120 million dollars in a Series D round led by Sixth Street Growth, with Oak HC/FT, 8VC and Y Combinator taking part, and that the round valued the company at three times its February 2025 Series C. The company reports 190 percent year-over-year annual contracted run-rate revenue growth and 180 percent year-over-year net dollar retention in 2025, says it serves more than 200 healthcare organisations, and frames the opportunity as the 280 billion dollars spent each year on revenue cycle management in the United States.
Why it matters: Net dollar retention of 180 percent means existing customers are spending far more each year, which is the strongest signal in this list because it is harder to manufacture than new sales. It also means the business model depends on expanding inside accounts, so a buyer should expect upsell pressure and should fix scope and pricing for more than one year. The 280 billion dollar figure is a market size, not a saving, and nothing here says what a single practice collects.
Careers and Qualifications
What to Know Before Applying
Work areas: The careers page is built around company values and employee stories rather than a role list, and sends candidates to an outside job board. The roles it shows include solutions consulting alongside engineering and leadership.
Qualification signal: Billing rules are the product here, so people who know payer behaviour and claim edits are worth more than people who only know machine learning. Someone who has worked a denial queue can tell you in a minute whether a demo is real.
Check current roles at Candid Health. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.
Related Healthcare AI Roles
Training to Compare
- Health information and data credentials ... American Health Information Management Association
- 10x10 informatics courses ... American Medical Informatics Association
Buyer Snapshot
- Best-fit buyer
- Chief financial officer, revenue cycle, coding, prior authorization, compliance, and patient financial services
- Primary use case
- Automate coding, claim review, authorization, payer calls, and administrative follow-up
- Typical deployment
- Usually connected to EHR, billing, claims, coding, payer portal, and contact-center workflows
Evidence questions
- What happens to denial rate, rework, days in accounts receivable, and net collections?
- Are results measured against a comparable baseline with all exception work included?
- How much human review remains for difficult or high-value cases?
Regulatory and workflow questions
- Who is accountable for coding accuracy and payer-facing representations?
- How are payer policy changes and coding rule changes incorporated?
- What audit trail exists for every automated action and override?
Data and contract questions
- Which clinical, claims, and financial data are accessed?
- How are credentials for payer and billing systems protected?
- Can exported decisions, evidence, and audit logs be retained if the contract ends?
Evidence and Regulation
FDA Clearances on Record
No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.